Cullinan Oncology
CGEM
CGEM
97 hedge funds and large institutions have $396M invested in Cullinan Oncology in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 22 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
97
Holders Change
-1
Holders Change %
-1.02%
% of All Funds
1.57%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
12
Increased
43
Reduced
22
Closed
12
Calls
$13K
Puts
$3K
Net Calls
+$10K
Net Calls Change
-$492K
Top Buyers
Top Sellers
| 1 |
BG
Baupost Group
Boston,
Massachusetts
|
$0 |
| 2 |
Goldman Sachs
New York
|
$1.77M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
$10.9M |
| 4 |
Morgan Stanley
New York
|
$2.37M |
| 5 |
Marshall Wace
London,
United Kingdom
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Two Sigma Advisers
New York
| – | -$192K | -15,000 | Closed |
|
|
CSS
102
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$180K | -14,015 | Closed |
|
103
Two Sigma Investments
New York
| – | -$168K | -13,100 | Closed |
|
104
Ensign Peak Advisors
Salt Lake City,
Utah
| – | -$31K | -2,400 | Closed |
|
105
Wells Fargo
San Francisco,
California
| – | -$1K | -71 | Closed |
|
|
S
106
SignatureFD
Atlanta,
Georgia
| – | -$1K | -64 | Closed |
|
107
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$14K | – | – |
|